The first definitive long-term repopulating hematopoietic stem cells (HSCs) emerge from and undergo rapid expansion in the embryonic aorta-gonad-mesonephros (AGM) region. To investigate the presumptive unique characteristics of the embryonic hematopoietic microenvironment and its surrounding tissues, we have generated stromal clones from subdissected day 10 and day 11 AGMs, embryonic livers (ELs) and gut mesentery. 
Introduction
A major clinical challenge in hematopoietic stem cell (HSC) transplantation is the establishment of culture systems that mediate extensive numerical expansion of HSCs in vitro with maintenance of HSC potential for proliferation and multilineage differentiation. Using well-defined early-acting cytokines, we and others have reported an increased ability of UCB cells for multilineage repopulation of NOD/SCID mice following ex vivo culture. [1] [2] [3] [4] In addition, several stromal cell lines derived from adult, fetal or embryonic origin have been shown to support HSCs and/or progenitors, emphasizing the role of microenvironment in promoting the survival, proliferation and differentiation of hematopoietic cells in vitro. [4] [5] [6] [7] [8] [9] However, the use of cytokines or stromal monolayers alone, or in combination, has met with limited success in expanding long-term repopulating HSCs for clinical applications, or improving rapid engraftment and early recovery of platelet and neutrophil numbers.
In the past few years, we have demonstrated that definitive murine HSCs and progenitors first emerge from the intraembryonic region, which forms the aorta, gonads, and mesonephros (AGM) region. 10 These hematopoietic cells capable of reconstituting definitive adult hematopoiesis first appear at day 10.5 after gestation (E10.5) and expand rapidly in the subsequent 2 to 3 days. Furthermore, from AGM explant cultures we learned that HSC activity is autonomously generated and amplified in the AGM. 10 In addition, we demonstrated that functional definitive HSCs developed particularly from the major arterial regions, ie the dorsal aorta, vitelline and umbilical vessels, indicating a close relationship between the developing hematopoietic and vascular systems. 11 The fetal liver, which is an important hematopoiesis-supportive microenvironment, does not become a major site for HSC expansion until E12. [12] [13] [14] In subsequent years, a few stromal cell lines from the E11 AGM region have been reported to maintain HSCs with competitive repopulating activity in vitro. 6, 9 However, this support did not seem to be better than that of earlier established stromal cell lines from E14.5 fetal liver or adult bone marrow. 7, 8 As the factors responsible for the induction and expansion of HSCs are still incompletely defined, we hypothesized that the E10 and E11 AGM region with surrounding tissues and the embryonic E11 liver (EL), display unique characteristics with regard to support of HSC activity and that the cloning of stromal cells from these regions would aid in identifying mechanisms involved in HSC expansion.
We have generated more than a hundred stromal clones from subdissected day 10 or 11 AGMs, ELs and gut mesentery of murine embryos transgenic for a temperature-sensitive mutant of the SV40 large T antigen (SV40 Tag) gene or the lacZ marker gene. 15 In the study presented here, we investigated the ability of 19 embryonic stromal clones to sustain extended Dexter-type LTCs of CD34 + umbilical cord blood (UCB) cells for periods as long as 12 weeks. Our previous experiments indicated that addition of the cytokines Flt3-L and Tpo results in superior maintenance of immature cobblestone area-forming cells (CAFC week6 ). 4, 16 Moreover, UCB cells cultured in the presence of at least these cytokines maintained their ability to undergo multilineage differentiation in vitro along myeloid and lymphoid pathways. 17, 18 The production of CAFC week6 or LTC-initiating cells(IC) in ex vivo expansion cultures has been shown to be indicative for the presence and quantity of in vivo repopulating HSC as measured using the quantitative NOD/SCID xenotransplant model. 3, 4, [19] [20] [21] However, behavior of the LTC-IC populations may only partly overlap with that of the HSC and show distinct characteristics under specific experimental conditions. 16, 22 Screening a large number of stromal cell lines using this in vivo model is not practical. Thus, we have used the in vitro production of CFC and CAFC week6 in extended LTC as a pseudo-assay for repopulating HSC instead. Using this assay we were able to identify several embryonic stromal co-cultures (one EL-, two UG-and one GI-derived) that supported an expansion of CAFC week6 largely exceeding that of the reference co-cultures under comparable conditions. All co-cultures required at least human Tpo for their prolonged expansion of human HSCs and progenitors.
Material and methods

Human umbilical cord blood cells
Human UCB samples were collected in sterile flasks containing 10 ml citrate-glucose as anticoagulant from umbilical cord vein after full-term delivery by the nursing staff of the Department of Obstetrics and Gynecology at the Sint Franciscus Gasthuis (Rotterdam, The Netherlands). UCB was stored at room temperature and processed within 24 h of collection. Lowdensity cells were isolated using Ficoll-Hypaque density centrifugation (1.077 g/cm 2 , Lymphoprep; Nycomed Pharma, Oslo, Norway) by centrifugation at 600 g for 15 min. The mononuclear cell (MNC) band at the interface was removed, washed twice with Hank's balanced salt solution (HBSS, Gibco, Breda, The Netherlands) and resuspended in Iscove's modified Dulbecco's medium (IMDM; Gibco). The MNCs were stored in 10% FCS, 20% DMSO in IMDM in liquid nitrogen until use.
Isolation of CD34
+ cells
In all experiments human UCB were positively selected for the expression of CD34 using either Variomacs or Automacs Immunomagnetic Separation System (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturer's instructions. After thawing and before the CD34 + hematopoietic progenitor cells were isolated we pooled three to 16 different UCB samples. The purity of the CD34 selected cells from UCB, as determined by FACS after staining with a CD34 antibody, was 90 ± 3%, and the percentage of cells with a CD34 +
CD38
− phenotype was 8 ± 7%. The progenitor and stem cell numbers in the input and output suspensions were determined by CFC and CAFC assays. The absolute number of progenitors present in uncultured material was 1.8 ± 1.0 × 10 4 and 2.7 ± 1.6 × 10 3 per 10 5 CD34 + cells for CFU-GM and CAFC week 6, respectively.
Hematopoietic growth factors
The following cytokines were used: recombinant human Flt3-L, a gift from Amgen (Thousand Oaks, CA, USA); recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), recombinant human granulocyte colony-stimulating factor (G-CSF) and recombinant murine stem cell factor (SCF), all gifts from Genetics Institute (Cambridge, MA, USA); recombinant human Tpo, a gift from Genentech (South San Francisco, CA, USA), recombinant human erythropoietin (EPO, Boehringer, Mannheim, Germany) and recombinant human interleukin-3 (IL3) (Gist Brocades, Delft, The Netherlands).
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Stromal cells and clones
The FBMD-1 cells were cultured as previously described. 23 The embryonic stromal clones were generated from subdissected AGM regions, gut and stomach tissues and livers from E10 and E11 embryos of BL1b, Tag05 and Tag11 mice with BL1b transgenic for lacZ inserted into the first intron and Tag 05/11 transgenic for temperature-sensitive mutant of the SV40 large T antigen. Details about the establishment of these stromal clones have been described elsewhere. 15 The embryonic stromal clones were cultured in 25 cm 2 flasks (Costar, Cambridge, MA, USA) with 5 ml IMDM containing 10% fetal calf serum (FCS; Summit, Fort Collins, CO, USA) and 10% horse serum (HS; Gibco), supplemented with penicillin (100 U/ml; Gibco), streptomycin (0.1 mg/ml; Gibco), ␤-mercaptoethanol (10 −4 M, Merck, Darmstadt, Germany). The stromal cells were grown to confluency at 33°C and 10% CO 2 and irradiated with 40 Gy prior to co-cultures.
Extended LTCs
Confluent 25 cm 2 flasks of different stromal cells were overlaid with 1 or 2 × 10 3 CD34 + UCB cells. These cells were cultured in 5 ml LTC-medium (IMDM containing 20% FCS, further supplemented with penicillin (100 U/ml), streptomycin (0.1 mg/ml), ␤-mercaptoethanol (10 −4 M; Merck), cholesterol (15 M, Sigma), linolic acid (15 M Merck), iron-saturated human transferrin (0.62 g/l; Intergen, Uithoorn, The Netherlands), nucleic acids (cytidine, adenosine, uridine, guanosine, 2Ј-deoxycytidine, 2Ј-deoxyadenosine, thymidine, 2Ј-deoxyguanosine (all at 10 −3 g/ml; Sigma)). The cultures were either supplemented with Tpo (10 ng/ml) alone or a combination of Flt3-L (50 ng/ml) and Tpo (10 ng/ml). In some experiments cells were also deposited on stromal layers without any cytokine supplements.
Depleted extended LTCs
Cultures were set up in quadruplicate and maintained at 33°C and 10% CO 2 for 12 weeks with weekly half medium change and consequently depletion of half of the non-adherent cells. Every 2 weeks the CFC output in non-adherent supernatant were determined without correcting for weekly demidepopulations. At weeks 7/8 or 12 the adherent layers were assayed for the CFC and CAFC numbers as well. Thus, the total CFC and CAFC production (in adherent plus non-adherent cells) could be determined at these timepoints. In the subsequent two experiments four stromal clones and one control line were set up in six-fold in flask cultures and the adherent and non-adherent compartments were analyzed separately for their progenitor and stem cell contents at weeks 2, 4 and 6 of culture. To harvest the adherent layer, the non-adherent cells were first collected and the layer washed with PBS and subsequently incubated with trypsin-EDTA (Life Technologies, Breda, The Netherlands) at 37°C for 5-10 min. The digestion was stopped by adding 1 ml FCS.
Non-depleted extended LTCs
In the last experiment, confluent layers of FBMD-1, UG26-1B6, EL08-1D2 and GI29-2B4 were irradiated with 40 Gy and seeded with 2 × 10 4 UCB CD34 + cells in LTC-medium additionally containing 1% bovine serum albumin (BSA; Sigma, Zwijndrecht, The Netherlands). Instead of weekly demidepopulating the non-adherent cells, these cultures were maintained by splitting the cultures every 4 weeks and seeding suitable aliquots of 5 × 10 3 and 1.25 × 10 3 input equivalents cells (both adherent and non-adherent cell fractions harvested and pooled) on two newly established corresponding stromal layers at weeks 4 and 8, respectively. The remaining number of cultured cells were analyzed for their progenitor and stem cell numbers using the CFC and CAFC assays every 4th week. Every 2 weeks the non-adherent fraction of the flask cultures was removed, centrifuged to collect the non-adherent cells, which were returned to the cultures, and replaced with fresh medium. The cytokines Flt3-L (50 ng/ml) and Tpo (10 ng/ml) were added twice weekly. The other culture conditions were the same as mentioned above.
Colony-forming cell assay
Granulocyte-macrophage colony-forming unit (CFU-GM) and burst-forming unit erythroid (BFU-E) progenitor cells were assayed using a semisolid culture medium (1.2% methylcellulose), in IMDM supplemented with 30% FCS, ␤-mercaptoethanol (5 × 10 −5 M), penicillin (100 U/ml), streptomycin (0.1 mg/ml), hu-EPO (1 U/ml), hu-IL3 (20 ng/ml), hu-GM-CSF (5 ng/ml), hu-G-CSF (50 ng/ml) and mu-SCF (100 ng/ml). Duplicate cultures were plated in 35-mm tissue culture dishes (Falcon) and incubated at 37°C and 10% CO 2 in a humidified atmosphere. Colonies containing 50 cells or more were scored at day 14 using an inverted light microscope.
Cobblestone area-forming cell assay
Confluent stromal layers of FBMD-1 cells in flat-bottom 96-well plates (Falcon) were overlaid with UCB cells in a limiting dilution set up as described. 24 Briefly, 12 successive two-fold dilutions were used for each sample with 15 wells per dilution. The percentage of wells with at least one phase-dark hematopoietic clone (cobblestone area) of at least five cells beneath the stromal layer was determined at week 6 (CAFC week6 ). The CAFC frequencies were calculated using Poisson statistics.
Immunophenotypic analysis
At least 50 000 fresh or cultured CD34
+ cells were stained with anti-human CD45/CD34/CD38 (allophycocyanin (APC)-, fluorescein isothiocyanate (FITC)-or phycoerythrin (PE)-conjugated) labeled monoclonal antibodies (Immunotech, Mijdrecht, The Netherlands). After incubation of the cells in phosphate-buffered saline (PBS; Life Technologies) containing 0.5% BSA and 2% normal human serum for 30 min on ice, the cells were washed in PBS with 0.5% BSA and resuspended in 0.35 ml PBS. Just before the acquisition 7-aminoactinomycin (7-AAD, Molecular Probes, Leiden, The Netherlands) was added to each sample to determine the viability of the cells. APC-, FITC-and PE-conjugated mouse isotype antibodies were used as control for each group. At least 10 000 events were acquired using fluorescence-activated cell sorting (FACS) analysis (Becton Dickinson). The flow cytometric analysis of a representative experiment is given in Figure 1 .
Statistical analysis
The values are reported as mean ± 1 s.d. The significance levels were determined by two-tailed Mann-Whitney U test analysis.
Results
The strategy for selecting functionally supportive embryonic stromal cell clones is shown in Figure 2 . In initial studies more than a hundred stromal clones from different embryonic tissues and subregions of the AGM, ie aorta-mesenchyme (AM), UG, EL and GI, were established from E10 and E11 mouse embryos transgenic for the temperature sensitive tsA58 mutant of the SV40 large T antigen gene or a control lacZ marker gene. 15 The stromal clones have been tested for their support of sustained generation of murine CFC in LTC. Twenty-five clones supported the growth of murine CFC better than several reference stromal lines. 25 Seven of these clones were able to maintain transplantable murine HSCs in a shortterm co-culture. Although prolonged culture decreased the maintenance of HSCs on most stromal clones, the urogenital ridge-derived clone, UG26-1B6, maintained in vivo repopulating murine HSCs for at least 4 weeks. For the evaluation of the functional support for human HSCs and progenitors 19
Figure 1
Flow cytometric analysis of uncultured and cultured CD34
+ UCB cells in a representative experiment. The FACS profiles represent the percentage of CD34 + UCB cells within the life-gate before and after 10 weeks of ex vivo culture on EL08-1D2 stromal cells under different conditions. The total CD34
+ percentage is given in the corner of the right quadrant for each sample. Cells were stained with CD34-FITC or CD34-APC and CD38-PE. The quadrants were set according to negative control samples labeled with IgG 1 -FITC or IgG 1 -APC and IgG 1 -PE.
Figure 2
Functional screening approaches of the newly established embryonic stromal clones.
best supportive embryonic stromal clones, including the seven which supported murine transplantable HSCs, were selected.
Generation of CFC and CD34 + subsets in extended long-term co-cultures with human CD34
+ UCB cells
Highly purified CD34 + cells from UCB were cultured on 21 different stromal layers, including the reference line FBMD-1, under serum-containing conditions for up to 12 weeks with medium containing either no cytokines, Tpo or Flt3-L + Tpo. We have previously shown that addition of these cytokines improves the maintenance of primitive CAFC week6 on FBMD1 stromal cells dramatically. 4 The stromal cells were grown to confluency and irradiated with 40 Gy prior to culture. In the first set of experiments we studied the ability of these stromal cells to sustain production of human progenitors in extended LTCs either in the absence or presence of cytokines. The extended LTCs were maintained by weekly half medium change resulting in removal of half of the non-adherent cells. The corresponding supernatants of the same cultures were pooled every 2 weeks and used to determine the CFU-GM production in the non-adherent compartment.
The non-adherent CFU-GM kinetics of the reference cell line and two representative clones are presented in Figure 3 . We observed a gradual decline in non-adherent CFU-GM production in the absence of cytokines with the majority of the stromal clones similar to the FBMD-1 reference line. In contrast, co-culture with the EL08-1D2 clone sustained human CFU-GM production under these conditions for more than 8 weeks. Moreover, the same clone supported the generation of more CFC than observed for the reference cell line FBMD-1 when either Tpo alone or a combination of Flt3-L and Tpo was added. In Figure 4 all stromal cell lines tested are plotted per embryonic region. Long-term non-adherent CFU-GM production was observed in cultures supported by stromal clones derived from all of the different embryonic regions. The limited number of clones did not allow statistical analyses of possible region-related differences in support. Cytokine supplementation dramatically improved the long-term nonadherent CFU-GM generation supported by stromal cell layers
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Figure 3
Extended generation of non-adherent CFU-GMs in three representative stromal co-cultures. Data represent one experiment with duplicate cultures. The cultures were maintained by weekly half medium change with removal of half of the non-adherent cells. The cells were assayed after pooling the corresponding cultures prior to CFC. The CFU-GM generation of the reference line FBMD-1 and two embryonic clones with distinct patterns are included for comparison. The CFU-GM and CAFC week 6 numbers present in uncultured material were 1.8 ± 1.0 × 10 4 and 2.7 ± 1.6 × 10 3 per 10 5 CD34 + UCB cells, respectively. AM, aorta mesenchyme; UG, urogenital ridge; EL, embryonic liver; GI, gastrointestinal tract.
derived from all regions. This resulted in a 30 to 700-fold significant increase in CFU-GM retrieved from Tpo-supplemented cultures as compared to control cultures on week 12 ( Figure 4 , P Ͻ 0.05, Mann-Whitney U test). The addition of Flt3-L to Tpo-complemented co-cultures showed no substantial improvement of the CFU-GM generation over that seen with TPO alone, except for weeks 2 and 4.
In addition to the functional screening, we also looked at the expression of CD34 and the CD34 + CD38 − cells as an indicator of progenitors and stem cells within the non-adherent compartment. The results of CD34 assessment after co-culture experiments with the reference cell line and two representative clones are shown in Figure 5 
Figure 4
Non-adherent CFU-GM generation with stromal cells from embryonic subregions in extended co-cultures. Data represent the mean non-adherent CFU-GM production in different stromal cocultures, averaged per subdissected region. The number of stromal clones averaged per region were 4-8, 2-9, 1-2, 1-2 and 2-3 for UG, AM, EL, GI regions and FBMD-1, respectively. The cultures were maintained by weekly half medium change with removal of half of the non-adherent cells. Mann-Whitney U test: P Ͻ 0.05 or P Ͻ 0.005 between cultures without and with supplementation of Tpo or Flt3-L + Tpo at all time points; P Ͻ 0.05 between Tpo and Flt3-L + Tpo supplemented cultures on weeks 2 and 4. Because there was no significant difference in non-adherent CFU-GM generation between the stromal cells with respect to their origin we pooled these groups for statistical analysis. AM, aorta mesenchyme; UG, urogenital ridge; EL, embryonic liver; GI, gastrointestinal tract.
cell production reached a maximum of 2330-fold the input with UG26-1B6 stromal cells at week 12 of co-culture (data not shown).
Stromal support for primitive stem and progenitor cells in human extended long-term co-cultures
To test whether the stromal clones supported the generation of primitive human progenitors, we determined the total (combined adherent and non-adherent cells) CFU-GM and CAFC week6 fractions of co-cultures after 7/8 and 12 weeks in the presence of Tpo alone or a combination of Flt3-L and Tpo. The embryonic stromal clones showed substantial variation in their ability to support primitive progenitors (Table 1) . Seven stromal co-cultures that maintained in vivo repopulating ability of murine HSCs are highlighted (bold type face) in Table 1 . Two of these clones, UG15-1B7 and UG26-2D3, did not long-term support human HSCs indicating different requirements of human HSCs for in vitro maintenance, or the lack of cross-specificity of one or more factors involved in the cross-talk between murine stromal cells and human progenitors. The clones GI29-2B4, UG26-1B6, UG26-3D4 and EL08-1D2, which most optimally support murine progenitors, also gave the best support for human HSCs and progenitors.
The distribution of stem and progenitor cells among adherent and non-adherent compartments in stromal co-cultures
The extended LTCs were maintained with half-medium changes each week and removal of half of the non-adherent Data represent one experiment with duplicate cultures. Values are given as percentage of input numbers generated in total (adherent + non-adherent) flask cultures at 7/8 or 12 weeks of co-cultures. The extended LTCs were maintained by weekly half medium change with removal of half of the non-adherent cells in the presence of cytokines. The cultured cells were assayed after pooling the corresponding cultures prior to CFC and CAFC assays. The CFU-GM and CAFC week 6 numbers present in uncultured material were 1.8 ± 1.0 × 10 4 and 2.7 ± 1.6 × 10 3 per 10 5 CD34 + UCB cells. Co-cultures with seven clones that maintained in vivo repopulating ability of murine HSC are highlighted (bold face). AM, aorta mesenchyme; UG, urogenital ridge; GI, gastrointestinal tract; EL, embryonic liver; ND, not determined.
cells. We observed that with some stromal clones only few cells adhered and realized therefore that the weekly depletion of half of all non-adherent cells would lead to a different depletion of HSCs and progenitors on different stromal cells. Therefore, we determined the percentage of CFU-GM in both adherent and non-adherent fractions of several stromal co-cultures of CD34 + UCB cells in the presence of Tpo or a combination of Flt3-L and Tpo. Remarkably, the different stromal clones showed different non-adherent proportions of CFU-GM at week 7/8 of the cultures for Tpo (range 7-95%) and Flt3-L + Tpo (range 8-100%) groups ( Table 2 ). The median nonadherent CFU-GM fraction was 66% (range 37-91%) and 60% (range 0-86%) at week 12 for the same groups (data not presented). We subsequently determined the stem cell and progenitor fractions in the adherent and non-adherent compartments with the best supportive stromal clones during the first 6 weeks of co-cultures in the presence of Flt3-L and Tpo. Non-adherent CFU-GM fraction in these co-cultures ranged from 40 to 90% (Table 3 ). All together, the majority (Ͼ80%) of the stromal clones contained most (30-90%) of the human progenitors in the non-adherent fraction during the 2-12 weeks of culture. Surprisingly, also high CAFC week6 numbers were contained in the non-adherent compartment of stromal co-cultures (Table 3 ). This observation is at variance with those of other investigators, who found that most primitive progenitors are located in the adherentnt of primary BM stromal co-cultures. [26] [27] [28] [29] [30] Our data indicate that the weekly halfmedium change in our culture system may have strongly affected the CFC and CAFC numbers in the total cultures leadLeukemia ing to an underestimation of the HSC and progenitor expansion.
In order to assess the full potential of stromal co-cultures to expand human HSCs and progenitors, we measured the expansion factor of HSCs and progenitors under conditions where no weekly depletion of non-adherent cells was applied. For this purpose we performed extended LTCs of CD34 + UCB cells on the three best supporting stromal clones and the reference line FBMD-1 in the presence of the cytokine combination Flt3-L + Tpo, because the addition of these cytokines resulted in superior maintenance of CAFC week6 in our previous FBMD-1 co-culture studies. 16 These cultures were maintained by splitting the flask cultures at weeks 4 and 8 and seeding the harvested cells on newly established corresponding stromal layers. Indeed, under these conditions a dramatic expansion of both CFU-GM and CAFC week6 was observed ( Table 4 ). The AGM region-derived stromal clone UG26-1B6 was superior in the expansion of CAFC week6 as compared to other clones tested and contained 825-fold more CAFC per culture as had been inoculated at the start of the experiment. However, the superior support of this stromal clone became only apparent after more than 8 weeks of in vitro propagation. During the whole culture time cobblestone areas and single phase dark cells were observed in high frequencies in the stromal layers.
Discussion
During murine development HSC activity has been found in the AGM region, vitelline and umbilical arteries, yolk-sac and Table 2 The proportion of progenitors present in the non-adherent compartment of extended long-term stromal co-cultures in the presence of cytokines Data represent one experiment with duplicate cultures. Values are given as percentage of total (adherent + non-adherent) numbers generated at 7/8 weeks of co-culture. The extended LTCs were maintained by weekly half medium change and thus removal of half of the non-adherent cells, in the presence of Flt3-L ± Tpo. The cultured cells were assayed after pooling the corresponding cultures prior to CFC assay. The adherent and non-adherent fractions of the corresponding stromal co-cultures were analyzed separately. AM, aorta mesenchyme; UG, urogenital ridge; GI, gastrointestinal tract; EL, embryonic liver; ND, not determined.
liver, suggesting that these sites provide a supportive microenvironment for maintenance and probably numerical expansion of these HSCs. However, the precise role of the microenvironment in these midgestational sites in maintenance and growth of human HSCs is largely unexplored. In the study presented here we have identified four embryonic stromal clones, two UG-, one GI-and one EL-derived, that support a dramatic expansion of CFU-GM and CAFC week6 during a 12 week co-culture with human CD34 + UCB cells in the pres- Data represent the mean of two independent experiments (± 1 s.d.) with duplicate cultures. Values are given as percentage of total (adherent + non-adherent) numbers generated at weeks 2, 4 or 6 in whole flask co-cultures. The extended LTCs were contained supplemental with Flt3-L + Tpo, and maintained by weekly half medium change with removal of half of the non-adherent cells. The cultured cells were assayed after pooling the corresponding cultures prior to CFC and CAFC assays. The adherent and non-adherent fractions of the corresponding stromal co-cultures were analyzed separately. UG, urogenital ridge; GI, gastrointestinal tract; EL, embryonic liver.
ence of at least Tpo. This expansion was higher than that obtainable with the FBMD-1 stromal line, known for its capability to maintain or expand HSC activity. Without addition of cytokines only one EL-derived cell clone maintained the CFU-GM generation for up to 12 weeks, while in the presence of at least Tpo in the stromal co-cultures a continuous HSC and progenitor production was supported by 12 out of 19 stromal clones. The limited number of stromal clones analyzed does not allow identification of the embryonic region that best supports the maintenance and expansion of human HSC subsets. Five out of seven stromal clones that supported murine in vivo repopulating HSCs also supported the generation of human newborn HSCs and progenitors in vitro. This strongly suggests that the factors responsible for in vivo expansion of murine HSCs in E11 AGM, GI and EL subregions also play an important role in the maintenance of newborn human HSCs in vitro and can be used to amplify the CFU-GM and CAFC week6 from CD34 + UCB cells. In contrast, two stromal clones, UG15-1B7 and UG26-2D3, supported murine but not human progenitors in long-term co-cultures. It might therefore be speculated that one or more UG stromal factors involved in maintenance or expansion of human CAFC week6 in extended LTC-CFC do(es) not have cross-species restrictions, or is(are) produced in sub-effective concentrations. Such factors could be derived from the murine stromal cells, but they could also be elaborated by the human progenitors and function to communicate with the stromal cells. In this context, it is of relevance to note that cytokine addition improved LTC-IC maintenance in part through interaction with progenitors and/or in part through interaction with stromal cells. 31, 32 Chemokines, such as the AGM-expressed WECHE, have been reported to inhibit the growth of progenitors. 33, 34 These data suggest that the ability of different AGM-derived stromal clones to support human HSCs and progenitors may be explained in part by proportionate differences in expression of stimulatory and inhibitory factors for HSC and progenitor expansion.
Although most of the embryonic clones used here were derived from different embryonic regions, we observed large variability in support of human HSCs and progenitors even between the clones derived from the same region. Such variability is most likely representative of the complex interplay between stroma and hematopoietic cells, regulated by adhesion molecules, extra-cellular matrix molecules, membrane-bound cytokines and cytokine receptors. Chemotactic factors such as SDF-1␣ may additionally help to guide and Table 4 The expansion of CFU-GM and CAFC week6 subsets after extended long-term stromal co-cultures without weekly depletion
Stromal
Total stem and progenitor cell subsets co-cultures (fold of input) maintain HSCs in their niches. [35] [36] [37] Previously, we showed that the presence of Tpo in long-term stromal co-cultures prolonged the hematopoietic activity and stimulated the generation of human progenitors for up to 25 weeks. 38 Recently, we demonstrated the synergistic role of stroma-cytokine combinations in expansion of human primitive progenitors. 16 In the present study, the addition of Tpo to different stromal cocultures often dramatically prolonged the hematopoietic activity, indicating the importance of this cytokine in longterm stromal survival of human HSCs. These data support and extend the requirement of Tpo to maintain HSCs in stromal co-cultures. 39 We show that a significant proportion of human CAFC and CFU-GM in co-cultures with a majority of murine stromal clones is found in the non-adherent compartment. We have also shown that both the adherent and non-adherent HSCs and progenitors can be gradually lost during extended cultures due to medium changes and that consequently the support of stromal clones for maintenance of HSCs and progenitors can be dramatically underestimated. In general, different methods are applied for maintenance of long-term stromal co-cultures. These include (1) half-medium changes each week and removal of half of the non-adherent cells as is the case in a part of our experiments, (2) medium changes without discarding cells, or (3) maintenance by splitting and refeeding the cultures with seeding the total number of harvested adherent and non-adherent cells on newly established stromal layers without discarding cells. All these methods will affect the number of HSCs and progenitors obtained after extended LTCs. It is generally assumed that in primary long-term cocultures the majority of the most primitive stem cells adheres to the stromal layer. For example, Mauch et al 40 showed that about one-third of murine spleen colony-forming cells (CFU-S) was contained in the non-adherent compartment of stromal co-cultures, however, the adherent CFU-S had greater 'selfrenewal' capacity than did non-adherent CFU-S. Whether our stromal cell lines differentially affect the extent of self-renewal in our extended LTC is presently under investigation. Our findings that a large proportion of HSCs and progenitors was present in the non-adherent fraction of extended LTCs demonLeukemia strate that the ability of stromal cell lines to sustain HSC and progenitor production cannot be evaluated on the basis of the adherent or non-adherent fraction alone.
In the present study, we describe a set of embryo-derived stromal cell lines capable of sustaining human hematopoiesis in extended cultures. These stromal cells provide us with tools to investigate factors required for in vitro maintenance of human hematopoiesis as well as possibly assist in establishing culture systems that may mediate numerical expansion of HSCs in vitro.
